Chemours
537 hedge funds and large institutions have $7.11B invested in Chemours in 2017 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 149 increasing their positions, 157 reducing their positions, and 71 closing their positions.
58% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 71
8% more funds holding
Funds holding: 499 → 537 (+38)
0% less ownership
Funds ownership: 76.72% → 76.72% (-0%)
1% less capital invested
Capital invested by funds: $7.18B → $7.11B (-$66.8M)
5% less repeat investments, than reductions
Existing positions increased: 149 | Existing positions reduced: 157
8% less call options, than puts
Call options by funds: $80.2M | Put options by funds: $86.9M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$288M |
| 2 |
BlackRock
New York
|
+$122M |
| 3 |
State Street
Boston,
Massachusetts
|
+$53.9M |
| 4 |
N
Natixis
Paris,
France
|
+$46.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$179M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$126M |
| 3 |
Two Sigma Investments
New York
|
-$90.8M |
| 4 |
Renaissance Technologies
New York
|
-$83.9M |
| 5 |
JP Morgan Chase
New York
|
-$81.4M |
CC Hedge Fund Activity: Q4 2017 in Review
537 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2017, worth a combined $7.11B — down 0.93% from $7.18B a quarter earlier.
Buyers outnumbered sellers: 112 funds opened new CC positions and 71 closed out — a net gain of 41 holders — while 149 added to existing stakes and 157 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $288M. The largest seller was Millennium Management, cutting an estimated $179M.
- 537 institutional investors held Chemours (CC) as of Q4 2017, up from 499 in Q3 2017.
- Funds reported $7.11B of Chemours stock for Q4 2017, down 0.93% quarter-over-quarter.
- 112 funds opened new Chemours positions in Q4 2017 and 71 closed out, a net change of +41 holders.
- The largest Chemours buyer in Q4 2017 was Fidelity Investments, an estimated $288M added.
- The largest Chemours seller in Q4 2017 was Millennium Management, an estimated $179M sold.
Based on aggregated 13F filings for Q4 2017.